Views: 15 Author: Site Editor Publish Time: 2026-10-12 Origin: Site
Medlere participated in Hospital Expo 2026 in Indonesia, held from October 7–10, 2026, at the Indonesia Convention Exhibition (ICE). The event provided a valuable opportunity to showcase Medlere’s in-vitro diagnostic (IVD) solutions, connect with healthcare professionals, and strengthen relationships with local partners.
During the exhibition, Medlere presented two of its key diagnostic platforms: the FiCA™ Immunofluorescence Analyzer and the UClia™ Chemiluminescence Immunoassay Analyzer.
The FiCA™ platform is designed to support rapid and reliable testing across a broad range of clinical applications, including inflammation, cardiac markers, thyroid function, fertility, and other areas of routine laboratory testing.
The UClia™ platform brings chemiluminescence immunoassay technology into a compact testing solution, offering an alternative approach for healthcare facilities seeking efficient, accurate and convenient diagnostic workflows.
Both platforms attracted interest from visitors, providing opportunities for discussions about product applications, laboratory needs, and potential cooperation in the Indonesian market.
In addition to the products displayed at the exhibition, Medlere’s M3 HPLC HbA1c Analyzer attracted considerable attention and generated numerous inquiries from visitors.
Based on high-performance liquid chromatography (HPLC) technology, the M3 is designed for HbA1c testing and hemoglobin variant analysis, supporting diabetes monitoring and the screening of conditions such as β-thalassemia.
The interest received during Hospital Expo 2026 highlighted the potential demand for advanced HbA1c testing solutions in Indonesia and created opportunities for further discussions with prospective partners and customers.
Medlere values its collaboration with local distributors and healthcare professionals in bringing diagnostic technologies closer to the people who need them. The exhibition was also an opportunity to spend time with the Indonesian team and partners, exchange market insights, and explore opportunities for future cooperation.
Medlere remains committed to advancing accessible and practical diagnostic solutions for laboratories and healthcare providers worldwide. Through continued product development and close collaboration with local partners, we aim to support the growth of the IVD market in Indonesia and beyond.
For more information about Medlere, please visit www.medlere.com or contact us at info@medlere.com.
